A senior industry executive with knowledge of B. Riley Financial confirmed to InvestmentNews on Monday that plans to split ...

B. Riley Securities has recently initiated Nektar Therapeutics (NKTR) stock to Buy rating, as announced on January 8, 2025, according to Finviz. Earlier, on December 10, 2024, H.C ...

B. Riley Securities Inc. has reached an agreement to end litigation that spanned two states with one its former top ...

BlackRock (BLK) disclosed a 5.1% passive stake in B. Riley Financial (RILY), which represents 1.54M shares. The filing with the SEC does not ...

Investment analysts at B. Riley issued their FY2027 earnings per share (EPS) estimates for GCT Semiconductor in a research note issued to investors on Monday, February 3rd. B. Riley analyst C. Ellis ...

In a report released today, Zach Cummins from B.Riley Financial maintained a Hold rating on Outbrain (OB – Research Report), with a price ...

B. Riley lowered the firm’s price target on Gentex (GNTX) to $32.50 from $37 and keeps a Buy rating on the shares following the Q4 report. The firm expects both the company’s sales and gross margin ...

On Tuesday, Fabrinet (FN) stock saw a decline, ending the day at $207.13 which represents a decrease of $-18.47 or -8.19% from the prior close of $225.6. The stock opened at $205.66 and touched a low ...

Fintel reports that on January 30, 2025, B. Riley Securities initiated coverage of Foghorn Therapeutics (NasdaqGM:FHTX) with ...

Learn about the latest financial trends and strategies in our comprehensive article written by a financial expert.

Investment analysts at B. Riley dropped their FY2024 earnings per share estimates for Warrior Met Coal in a report issued on Thursday, January 30th. B. Riley analyst N. Giles now anticipates that the ...

B. Riley Financial Inc., seeking to recover from soured investments and a string of losses, has briefed its staff on a tentative plan to spin off its securities business into a separate company.